Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
biotech
7
×
investing
7
×
life sciences
national blog main
venture capital
7
×
boston blog main
boston top stories
clinical trials
national top stories
san francisco blog main
deals
new york blog main
raleigh-durham blog main
roche
san francisco top stories
boston
cancer
fda
indiana blog main
medical devices
new york top stories
raleigh-durham top stories
san diego blog main
seattle blog main
startups
amgen
boulder/denver blog main
boulder/denver top stories
cell therapy
detroit blog main
detroit top stories
diabetes
diagnostics
drugs
indiana top stories
national
novartis
revolution medicines
san diego top stories
seattle top stories
What
million
new
patients
bio
drug
drugs
medicines
research
roundup
startup
advantages
ahead
aims
analytics
asco
backed
bar
beta
biofourmis
bionics
blood
branded
brings
cancer
cash
cause
ceo
choices
closed
commissioner
committed
consumers
costly
counterweight
data
deploy
despite
developing
device
devices
Language
unset
Current search:
investing
×
photo
×
" venture capital "
×
biotech
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests